- POSITIVE
Annual Revenue Aristo Bio-Tech Mar-2026 Annual Revenue is Rs 364 Cr which is growth of 14.3% YoY.
- POSITIVE
Annual Net Profit Aristo Bio-Tech Mar-2026 Annual Net Profit is Rs 7 Cr which is growth of 76.8% YoY.
NSE: ARISTO
Aristo Bio-Tech Live Share Price Today, Share Analysis and Chart
aboutAristo Bio-Tech and Lifescience Ltd. is an agrochemical company based in India, primarily engaged in the manufacturing, formulation, and supply of various crop protection products. The company operates in the agrochemicals industry, providing solutio... Read More
86.000.00(0.00%)
3,200
NSE Volume
NSE 30 Oct, 2026 3:31 PM (IST)
Please subscribe to view forecaster data
Check Before You Buy
VIEW FULL CHECKLISTHigh rank
8Positive6Negative
Pass in checklist57.1%
Check P/E Buy Sell Zone
Not enough data available
Aristo Bio-Tech Stock Price Analysis
Month Price Range-6.5% 1 Month return | 86 (LTP) 8594 LowHigh |
|---|---|
52 Week Price Range-34.8% 1 Year return | 86 (LTP) 74.3135 LowHigh |
Competitors/Peers
Annual
Balance Sheet
Ratios
Cash Flow
Documents
Aristo Bio-Tech annual results: revenue, profit, P&L, and margins as of Mar 2026 – 11 year history
Nested row level
Base Level
Reporting Type
Standalone
Cell Data
Actual
Table Settings
YoY & New to Old
CAGR Columns
Select...
Nested row level
Base Level
Export
| Indicator | Graph | CAGR 3 Yrs | CAGR 5 Yrs | Mar '26 | Mar '25 | Mar '24 | Mar '23 | Mar '22 | Mar '21 | Mar '20 | Mar '19 |
|---|---|---|---|---|---|---|---|---|---|---|---|
18.6% | 16.8% | 364.2 | 318.6 | 245.3 | 218.2 | 166 | 167.2 | 201.2 | 201.8 | ||
Operating Exp. Ann. | 18.5% | 16.4% | 347.7 | 308.8 | 236.7 | 209.2 | 160.5 | 162.9 | 196.7 | 194.9 | |
Operating Profit Ann. | 22.8% | 30.2% | 16.1 | 9.3 | 8.5 | 8.7 | 5.5 | 4.3 | 3.4 | 5 | |
OPM Ann. % | 3.4% | 11.1% | 4.41% | 2.91% | 3.46% | 3.99% | 3.29% | 2.60% | 1.69% | 2.49% | |
18.4% | 16.4% | 354.5 | 313.1 | 239.9 | 213.4 | 164 | 165.7 | 199.8 | 197.6 | ||
EBITDA Ann. | 22.4% | 30.3% | 16.5 | 9.7 | 8.7 | 9 | 5.5 | 4.4 | 4.5 | 6.9 | |
EBITDA Ann. margin % | 3% | 11.7% | 4.53% | 3.05% | 3.54% | 4.14% | 3.31% | 2.60% | 2.24% | 3.43% | |
Interest Ann. | 11.7% | 13.2% | 3.9 | 1.7 | 1.7 | 2.8 | 2.4 | 2.1 | 2.6 | 2.3 | |
Depr. | 24.6% | 29.4% | 2.9 | 2.6 | 1.6 | 1.5 | 1.1 | 0.8 | 0.5 | 0.5 | |
PBT Ann. | 27.3% | 45.3% | 9.7 | 5.5 | 5.4 | 4.7 | 2 | 1.5 | 1.4 | 4.2 | |
Tax Ann. | 27.7% | 44.3% | 2.5 | 1.4 | 1.5 | 1.2 | 0.6 | 0.4 | 0.4 | 1.2 | |
26% | 45.6% | 7.2 | 4.1 | 3.9 | 3.6 | 1.5 | 1.1 | 1 | 2.9 | ||
Net Profit Ann. | 26% | 45.6% | 7.2 | 4.1 | 3.9 | 3.6 | 1.5 | 1.1 | 1 | 2.9 | |
NPM Ann. % | 6.5% | 25.2% | 1.97% | 1.27% | 1.58% | 1.63% | 0.88% | 0.64% | 0.48% | 1.46% | |
EPS Adj. latest Ann. | 26.8% | 46% | 10.6 | 6 | 5.7 | 5.2 | 2.2 | 1.6 | 1.4 | 4.3 |
*All financials are in INR Cr and price data in INR
Add metric to table
Search...
Total Rev. Ann.
1Y CHG
14.3%
2Y CAGR
21.8%
3Y CAGR
18.6%
5Y CAGR
16.8%
7Y CAGR
8.8%
Total Revenue Annual growth is stable compared to historical averages.
Net Profit Ann.
1Y CHG
75.6%
2Y CAGR
35.9%
3Y CAGR
26%
5Y CAGR
45.6%
7Y CAGR
13.9%
Net Profit Annual growth is higher than historical averages.
Operating Exp. Ann.
1Y CHG
12.6%
2Y CAGR
21.2%
3Y CAGR
18.5%
5Y CAGR
16.4%
7Y CAGR
8.6%
Operating Expenses Annual Cr growth is stable compared to historical averages.
Aristo Bio-Tech Technical Analysis
Aristo Bio-Tech EMA & SMA
Bearish-8
0 bullish, 8 bearish
Bullish0
Bearish8
| 5 Day | 87.3 |
|---|---|
| 10 Day | 89.7 |
| 12 Day | 90.7 |
| 20 Day | 93.7 |
| 26 Day | 95.1 |
|---|---|
| 50 Day | 98.3 |
| 100 Day | 102.7 |
| 200 Day | 107.9 |
Aristo Bio-Tech Delivery And Volume
Daily Avg. Delivery Volume %
30 Oct, 2026100.0%
Week100.0%
Month-
Legend
Positive IndicatorNeutral IndicatorNegative Indicator
Aristo Bio-Tech Resistance and Support
86.00
Pivot
| First Resistance | 86 |
|---|---|
| Second Resistance | 86 |
| Third Resistance | 86 |
| First Support | 86 |
|---|---|
| Second Support | 86 |
| Third Support | 86 |
| Day RSI | 34.6 |
|---|---|
| Day MACD | -4.5 |
| Day MFI | 23 |
| Day MACD Signal Line | -3.4 |
Aristo Bio-Tech Beta
| 1 Month | -1.9 |
|---|---|
| 1 Year | -0.1 |
| 3 Month | -0.6 |
|---|---|
| 3 Year | - |
Aristo Bio-Tech Price Change Analysis
↓-6.5%
Over 1 Month
LowHigh
8594
↓-21.3%
Over 3 Months
LowHigh
85113.4
↓-28.3%
Over 6 Months
LowHigh
85122.8
↓-34.9%
Over 1 Year
LowHigh
74.3135
Aristo Bio-Tech Deals - Insider, Bulk, Block and SAST
| Client Name | Deal Type | Action | Date | Avg. Price | Quantity | Exchange |
|---|---|---|---|---|---|---|
| SUHAS ASHTAPUTRE | Bulk | Sell | 04 Apr 2025 | 129.23 | 35,200 | NSE |
| SUHAS ASHTAPUTRE | Bulk | Purchase | 04 Apr 2025 | 141.40 | 1,600 | NSE |
| SHREYAS V SHAH (HUF) | Bulk | Sell | 28 Mar 2025 | 108.54 | 65,600 | NSE |
| FALGUNI SHREYASH SHAH | Bulk | Purchase | 28 Mar 2025 | 108.81 | 67,200 | NSE |
| SUNIL MURLIMANOHAR KABRA | Bulk | Purchase | 26 Mar 2025 | 97.11 | 36,800 | NSE |
| SHREYAS V SHAH (HUF) | Bulk | Purchase | 29 Oct 2024 | 146.49 | 40,000 | NSE |
| FALGUNI SHREYASH SHAH | Bulk | Sell | 17 Oct 2024 | 93.96 | 73,600 | NSE |
| SUNIL MURLIMANOHAR KABRA | Bulk | Purchase | 17 Oct 2024 | 93.58 | 68,800 | NSE |
| FALGUNI SHREYASH SHAH | Bulk | Purchase | 17 Oct 2024 | 122.36 | 11,200 | NSE |
| FALGUNI SHREYASH SHAH | Bulk | Sell | 10 Jun 2024 | 77.50 | 52,800 | NSE |
Aristo Bio-Tech Corporate Actions
Aristo Bio-Tech Dividend history and yield
Aristo Bio-Tech dividend yields, including actual and adjusted, and dividend history, including announcement, record, and ex-dividend dates. Track Aristo Bio-Tech dividend yield over time.
#Ex-Date | Dividend Amount | Dividend Type | Record Date | Instrument Type |
|---|---|---|---|---|
123 Sep 2026 | 0.6 | FINAL | 23 Sep 2026 | Equity Share |
201 Sep 2025 | 0.5 | FINAL | 01 Sep 2025 | Equity Share |
313 Sep 2024 | 0.4 | FINAL | 13 Sep 2024 | Equity Share |
415 Sep 2023 | 0.25 | FINAL | 15 Sep 2023 | Equity Share |
Aristo Bio-Tech Board Meetings
Aristo Bio-Tech past and upcoming board meetings.
#Ex-Date | Purpose | Notes |
|---|---|---|
130 May 2026 | Audited Results, Dividend & Others | To consider other business matters. (Revised) |
214 Nov 2025 | Quarterly Results & Others | To consider other business matters. |
329 May 2025 | Audited Results, Dividend & Others | To consider other business matters. |
413 Nov 2024 | Quarterly Results & Others | To consider other business matters. |
527 May 2024 | Audited Results & Dividend | - |
Aristo Bio-Tech Documents
Aristo Bio-Tech Credit Ratings
Aristo Bio-Tech credit ratings from CRISIL and leading rating agencies, assessing financial stability, investment grade, and related PDF documentation.
| Date | Rating Agency | Company Name | Description | Links |
|---|---|---|---|---|
| 05 Oct 2026 | crisil ratings | Aristo Biotech and Life Science Limited | Aristo Biotech and Life Science Limited:Issuer not cooperating, based on best-available information; Ratings revised to 'Crisil B/Stable/Crisil A4 Issuer not cooperating\u2019 | Link |
| 30 Jul 2025 | crisil ratings | Aristo Biotech and Life Science Limited | Aristo Biotech and Life Science Limited:Issuer not cooperating, based on best-available information; Ratings continues to be \u2018Crisil B/Stable/Crisil A4 Issuer not cooperating\u2019 | Link |
Aristo Bio-Tech - Company Profile
Aristo Bio-Tech Management Structure
Aristo Bio-Tech management structure with salaries, total experience, and qualifications.
Aristo Bio-Tech Board of Directors
Aristo Bio-Tech Board of directors with salaries, total experience, and qualifications.
Website: www.aristobiotech.com
About the company - Business Profile
Aristo Bio-Tech and Lifescience Ltd. is an agrochemical company based in India, primarily engaged in the manufacturing, formulation, and supply of various crop protection products. The company operates in the agrochemicals industry, providing solutions such as insecticides, herbicides, and fungicides to protect crops from pests and diseases, thereby supporting agricultural productivity.
Key Points
- Key Facts:
- Founded Year: 2005
- Headquarters: Vadodara, Gujarat, India.
- Stock Listing: Listed on the NSE Emerge platform (SME segment).
- Core Offerings: Agrochemical formulations including insecticides, herbicides, fungicides, and plant growth regulators.
- Operations and Resources:
- Facilities: The company operates a manufacturing unit located at Manjusar, GIDC, Savli, Vadodara, Gujarat. This facility is equipped to handle various formulation types like EC (Emulsifiable Concentrate), SC (Suspension Concentrate), and WP (Wettable Powder).
- Integration: The company focuses on the formulation segment of the agrochemical value chain, sourcing technical-grade chemicals and converting them into finished branded or contract-manufactured products.
- Ownership:
- The company was promoted by Mr. Narendra Singh Barhat and Mrs. Kusum Narendra Singh Barhat. It successfully transitioned from a private entity to a publicly listed company following its IPO in early 2023.
- Market Significance:
- Industries Served: Primarily the agricultural sector, catering to farmers through a distribution network and providing contract manufacturing (job work) services to larger agrochemical players.
- Strategic Importance: Plays a role in the Indian government's push for increased agricultural output and "Make in India" initiatives within the chemical sector.
- Business Model and Strengths:
- Model: Aristo Bio-Tech operates on a dual model of selling its own branded formulations and performing contract manufacturing for other domestic and multinational companies.
- Strengths: Expertise in diverse formulation technologies and a strong presence in the Gujarat industrial hub, which provides logistical advantages for sourcing and distribution.
- Revenue Breakdown (FY24 Annual):
- Total Revenue from Operations: Approximately ₹240 - ₹260 crore for FY24 (based on reported performance trends).
- Segmental Revenue: The company operates in a single reportable segment: Manufacturing and Trading of Agrochemicals.
- Geographical Mix: Predominantly domestic (India), with a focus on states like Gujarat, Maharashtra, and Madhya Pradesh.
- Key Products and Services:
- Insecticides: Products targeting a wide range of crop pests.
- Herbicides: Formulations for weed management.
- Fungicides: Solutions for fungal disease control.
- Plant Growth Regulators: Specialized chemicals to enhance crop yield and quality.
- Strategic Initiatives and Outlook:
- Expansion: Focus on expanding its product registration portfolio to include more specialized and high-margin molecules.
- Market Reach: Strengthening the dealer-distributor network across Northern and Western India to increase the share of branded sales versus contract manufacturing.
- Future Outlook: The company aims to capitalize on the rising demand for crop protection in India and explore export opportunities for its formulation products.